Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.715
+0.025 (1.48%)
Aug 15, 2025, 10:19 AM - Market open
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.99 million as of August 15, 2025. Its market cap has decreased by -51.65% in one year.
Market Cap
9.99M
Enterprise Value
-6.11M
1-Year Change
-51.65%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.99M, a decrease of -47.24%. That is a compound annual growth rate of -18.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 9.84M | -44.94% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |